Synthesis and Structure−Activity Relationship of Small-Molecule Malonyl Coenzyme A Decarboxylase Inhibitors-Reference-Cited by-同舟云学术

Synthesis and Structure−Activity Relationship of Small-Molecule Malonyl Coenzyme A Decarboxylase Inhibitors

Published:2006-02-11 Issue:5 Volume:49 Page:1517-1525
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cheng Jie-Fei¹,Chen Mi¹,Wallace David¹,Tith Souvothy¹,Haramura Masayuki¹,Liu Bin¹,Mak Chi Ching¹,Arrhenius Thomas¹,Reily Sean¹,Brown Steven¹,Thorn Vicki¹,Harmon Charles¹,Barr Rick¹,Dyck Jason R. B.¹,Lopaschuk Gary D.¹,Nadzan Alex M.¹

Affiliation:

1. Departments of Chemistry and Discovery Biology, Chugai Pharma USA, LLC., 6225 Nancy Ridge Drive, San Diego, California 92121, and Metabolic Modulator Research Ltd. (MMRL), 2020 Research Transition Facility, University of Alberta, Edmonton, Alberta, Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm050109n

Reference36 articles.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials;Pharmacological Reviews;2022-06-16

2. Cardiac metabolism — A promising therapeutic target for heart failure;Pharmacology & Therapeutics;2018-02

3. Design, synthesis and in vitro evaluation of some small molecules malonyl CoA decarboxylase inhibitors containing pyrazoline scaffold and study of their binding interactions with malonyl CoA decarboxylase via preliminary docking simulation;Medicinal Chemistry Research;2017-05-22

4. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure;International Journal of Cardiology;2016-01

5. Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets;Antioxidants & Redox Signaling;2015-06-10